Arthur C Butcher
CIK 1678249 · EVP& Grp Pres, MedSurg & APAC · last filed 2026-06-22
Arthur C Butcher is an EVP& Grp Pres, MedSurg & APAC who has filed 99 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for STAA, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$60.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.6M across reported positions. 95 SEC filings were submitted jointly with BOSTON SCIENTIFIC CORP. 11 Form 144 notices of planned sales are also on file; the latest, for BSX on Dec 1, 2025, lists the filer as an officer.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BSX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752
Holdings By Company
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| BSX | Direct | 56,887 | 73.8% | 2026-05-04 |
| By 401(k) | 20,228 | 26.2% | 2026-05-04 | |
| Total | 77,115 |
10b5-1 Trading Plans
3 plans · 1 in force| Company | Adopted | Sales Can Start | Ends | Plan Allows | Sold So Far | Status | Link |
|---|---|---|---|---|---|---|---|
| BSX Executive Vice President and Group President, MedSurg and Asia Pacific |
Aug 28, 2025 | Nov 26, 2025 | Feb 1, 2027 | 162,648 shares | None filed | Active | 10-Q |
| BSX Executive Vice President and Group President, MedSurg and Asia Pacific |
Aug 9, 2024 | Nov 7, 2024 | Jan 30, 2026 | 69,253 shares | 69,253 (100%) last filed Dec 2, 2025 |
Ended | 10-Q |
| BSX Executive Vice President and Group President, MedSurg and Asia Pacific |
Nov 22, 2023 | Feb 22, 2024 | Jan 31, 2025 | 148,943 shares | 51,368 (34%) last filed Nov 25, 2024 |
Ended | 10-K |
Recent Filings
99 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-22 | STAA | Mixed | +5,341 | $0 | EDGAR |
| 2026-05-04 | BSX | Mixed | +1,095 | -$56.9K | EDGAR |
| 2026-02-27 | BSX | Disc (I) | +6,851 | $519.0K | EDGAR |
| 2026-02-18 | BSX | Mixed | +30,802 | -$2.09M | EDGAR |
| 2026-02-17 | BSX | Mixed | +1,390 | -$96.5K | EDGAR |
| 2025-12-02 | BSX | Mixed10b5-1 Plan adopted Aug 9, 2024 |
— | -$1.33M | EDGAR |
| 2025-12-01 | BSX | Notice (144) Officer · Planned Dec 1, 2025 · 10b5-1 plan Sold: Form 4 filed Dec 2, 2025 |
−17,313 | -$1.76M | EDGAR |
| 2025-08-04 | BSX | Mixed10b5-1 Plan adopted Aug 9, 2024 |
— | -$1.38M | EDGAR |
| 2025-08-01 | BSX | Notice (144) Officer · Planned Aug 1, 2025 · 10b5-1 plan Sold: Form 4 filed Aug 4, 2025 |
−17,313 | -$1.81M | EDGAR |
| 2025-06-20 | STAA | Grant (A) | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).